0001493152-19-014809.txt : 20191001 0001493152-19-014809.hdr.sgml : 20191001 20191001161634 ACCESSION NUMBER: 0001493152-19-014809 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191001 DATE AS OF CHANGE: 20191001 EFFECTIVENESS DATE: 20191001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aeterna Zentaris Inc. CENTRAL INDEX KEY: 0001113423 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350092 FILM NUMBER: 191129305 BUSINESS ADDRESS: STREET 1: C/O STIKEMAN ELLIOTT LLP STREET 2: 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR CITY: MONTREAL STATE: A8 ZIP: H3B 3V2 BUSINESS PHONE: 843-900-3201 MAIL ADDRESS: STREET 1: C/O STIKEMAN ELLIOTT LLP STREET 2: 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR CITY: MONTREAL STATE: A8 ZIP: H3B 3V2 FORMER COMPANY: FORMER CONFORMED NAME: AETERNA LABORATORIES INC DATE OF NAME CHANGE: 20000503 D 1 primary_doc.xml X0708 D LIVE 0001113423 Aeterna Zentaris Inc. 315 SIGMA DRIVE SUMMERVILLE SC SOUTH CAROLINA 29486 843-900-3201 CANADA (FEDERAL LEVEL) Aeterna Laboratories Inc. AETERNA LABORATORIES INC Corporation true Michael V. Ward 315 Sigma Drive Summerville SC SOUTH CAROLINA 29486 Executive Officer Leslie Auld 315 Sigma Drive Summerville SC SOUTH CAROLINA 29486 Executive Officer Klaus Paulini Weismullerstrasse 50 Frankfurt 2M GERMANY 60314 Executive Officer Nicola Ammer Weismullerstrasse 50 Frankfurt 2M GERMANY 60314 Executive Officer Carolyn Egbert 315 Sigma Drive Summerville SC SOUTH CAROLINA 29486 Director Robin Smith Hoke 315 Sigma Drive Summerville SC SOUTH CAROLINA 29486 Director Gerard Limoges Weismullerstrasse 50 Frankfurt 2M GERMANY 60314 Director Brent Norton 315 Sigma Drive Summerville SC SOUTH CAROLINA 29486 Director Pharmaceuticals Decline to Disclose 06b false 2019-09-20 false true true false 0 Maxim Group LLC 120708 None None 405 LEXINGTON AVENUE NEW YORK NY NEW YORK 10174 NY NEW YORK false 4987500 4987500 0 The issuer received gross proceeds of $4,987,500 from the issuance of 3,325,000 common shares in a registered direct offering and a concurrent private placement of warrants to purchase up to 3,325,000 common shares. false 4 349125 0 The commissions were based on gross proceeds of the registered direct offering of common shares that was concurrent with the private placement of unregistered warrants. 0 false Aeterna Zentaris Inc. /s/ Michael V. Ward Michael V. Ward President and CEO 2019-10-01